599
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Antidepressant-like Effect of Paeonol

, , &
Pages 229-235 | Accepted 27 Jan 2006, Published online: 07 Oct 2008
 

Abstract

The current study investigated the putative antidepressant-like effect of paeonol, a phenolic component from the root bark of Paeonia suffruticosa. Andr. (Ranunculaceae), in mice or rats using the tail suspension test (TST) and forced swimming test (FST), two widely accepted pharmacological models for detecting antidepressant activity in modern medicinal researchers. It was found that paeonol, at doses of 20, 40, and 80 mg/kg (p.o.), reduced immobility time in TST and FST in mice. Paeonol also decreased immobility time at 25 and 50 mg/kg (p.o.) in the FST in rats. Furthermore, paeonol as well as fluoxetine (FLU), at the doses tested, did not produce significant effects on locomotor activity. With 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay and lactic dehydrogenase (LDH) assay, 5, 10, and 20 µM paeonol or a classical antidepressant, 10 µM FLU, protected PC12 cells from the lesion induced by 10 µM corticosterone (Cort) treatment for 48 h. In the fura-2/AM (acetoxymethyl ester) labeling assay, 10 and 20 µM paeonol, 10 µM FLU attenuated the intracellular Ca2+ overloading induced by 200 µM Cort treatment for 48 h in PC12 cells. In summary, we first demonstrated that paeonol possessed an antidepressant-like action through the protection of PC12 cells as well as reversal intracellular Ca2+ overloading.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.